Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease

Cerebrovascular Diseases

Volumn 33, Issue 5, 2012, Pages 436-445

  Fujimura, Miki ^a,b   Inoue, Takashi ^b   Shimizu, Hiroaki ^c   Saito, Atsushi ^b   Mugikura, Shunji ^c   Tominaga, Teiji ^c  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Blood pressure lowering; Cerebral hyperperfusion; Extracranial intracranial bypass; Moyamoya disease; Postoperative management

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; IOFETAMINE I 123; NICARDIPINE;

ADOLESCENT; ADULT; AGED; ANTIHYPERTENSIVE THERAPY; APHASIA; ARTICLE; BRAIN BLOOD FLOW; CEREBRAL HYPERPERFUSION; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR DISEASE; CHILD; CLINICAL TRIAL; CONTINUOUS INFUSION; DYSARTHRIA; FACIAL NERVE PARALYSIS; FEMALE; FOLLOW UP; HEMIPARESIS; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY; MOYAMOYA DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENSORY DYSFUNCTION; SIMPLE PARTIAL SEIZURE; SUBARACHNOID HEMORRHAGE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AMPHETAMINES; ANASTOMOSIS, SURGICAL; ANTIHYPERTENSIVE AGENTS; AUTORADIOGRAPHY; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; CEREBRAL REVASCULARIZATION; CEREBROVASCULAR CIRCULATION; CEREBROVASCULAR DISORDERS; CHILD; CHILD, PRESCHOOL; CLINICAL PROTOCOLS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOYAMOYA DISEASE; ODDS RATIO; POSTOPERATIVE CARE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 84858990484     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000336765     Document Type: Article

References (41)

1. Suzuki J, Takaku A: Cerebrovascular 'moyamoya' disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288-299.
2. Fujimura M, Kaneta T, Tominaga T: Efficacy of superficial temporal artery-middle cerebral artery anastomosis with routine postoperative cerebral blood flow measurement during the acute stage in childhood moyamoya disease. Childs Nerv Syst 2008; 24: 827-832.
3. Fujimura M, Mugikura S, Kaneta T, Shimizu H, Tominaga T: Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease. Surg Neurol 2009; 71: 442-447.
4. Guzman R, Lee M, Achrol A, Bell-Stephens T, Kelly M, Do HM, Marks MP, Steinberg GK: Clinical outcome after 450 revascularization procedures for moyamoya disease. J Neurosurg 2009; 111: 927-935.
5. Houkin K, Ishikawa T, Yoshimoto T, Abe H: Direct and indirect revascularization for moyamoya disease: Surgical techniques and peri-operative complications. Clin Neurol Neurosurg 1997; 99(suppl 2):S142-S145. (Pubitemid 27489083)
6. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C: Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: Cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 1998; 29: 625-630. (Pubitemid 28145789)
7. Piepgras DG, Morgan MK, Sundt TM Jr, Yanagihara T, Mussman LM: Intracerebral hemorrhage after carotid endarterectomy. J Neurosurg 1988; 68: 532-536.
8. Solomon RA, Loftus CM, Quest DO, Correll JW: Incidence and etiology of intracerebral hemorrhage following carotid endarterectomy. J Neurosurg 1986; 64: 29-34. (Pubitemid 16189595)
9. Sundt TM Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM, O'Fallon WM: Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc 1981; 56: 533-543. (Pubitemid 12230956)
10. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T: Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 2007; 67: 273-282. (Pubitemid 46274903)
11. Furuya K, Kawahara N, Morita A, Momose T, Aoki S, Kirino T: Focal hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease. Case report. J Neurosurg 2004; 100: 128-132. (Pubitemid 38017828)
12. Kim JE, Oh CW, Kwon OK, Park SQ, Kim SE, Kim YK: Transient hyperperfusion after superficial temporal artery/middle cerebral artery bypass surgery as a possible cause of postoperative transient neurological deterioration. Cerebrovasc Dis 2008; 25: 580-586. (Pubitemid 351861478)
13. Kohama M, Fujimura M, Mugikura S, Tominaga T: Temporal change of 3-T magnetic resonance imaging/angiography during symptomatic cerebral hyperperfusion following superficial temporal artery-middle cerebral artery anastomosis in a patient with adult-onset moyamoya disease. Neurosurg Rev 2008; 31: 451-455.
14. Nakagawa A, Fujimura M, Arafune T, Sakuma I, Tominaga T: Clinical implications of intraoperative infrared brain surface monitoring during superficial temporal arterymiddle cerebral artery anastomosis in patients with moyamoya disease. J Neurosurg 2009; 111: 1158-1164.
15. Ogasawara K, Komoribayashi N, Kobayashi M, Fukuda T, Inoue T, Yamada K, Ogawa A: Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: Case report. Neurosurgery 2005; 56:E1380.
16. Ohue S, Kumon Y, Kohno K, Watanabe H, Iwata S, Ohnishi T: Postoperative temporary neurological deficits in adults with moyamoya disease. Surg Neurol 2008; 69: 281-286. (Pubitemid 351312774)
17. Fujimura M, Shimizu H, Mugikura S, Tominaga T: Delayed intracerebral hemorrhage after superficial temporal artery-middle cerebral artery anastomosis in a patient with moyamoya disease: Possible involvement of cerebral hyperperfusion and increased vascular permeability. Surg Neurol 2009; 71: 223-227.
18. Fujimura M, Shimizu H, Inoue T, Mugikura S, Saito A, Tominaga T: Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after EC-IC bypass for moyamoya disease: Comparative study with non-moyamoya patients using 123 I-IMP-SPECT. Neurosurgery 2011; 68: 957-965.
19. Khan N, Schuknecht B, Boltshauser E, Capone A, Buck A, Imhof HG, Yonekawa Y: Moyamoya disease and moyamoya syndrome: Experience in Europe: Choice of revascularisation procedures. Acta Neurochir (Wien) 2003; 145: 1061-1071. (Pubitemid 38091021)
20. Tominaga T, Fujimura M: Outcome of revascularization surgery for moyamoya disease under standardized peri-operative management protocol. Annual Report by the Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of Health and Labour Science Research Grants (in Japanese). Res Measures Intract Dis (Japan) 2009; 30: 5-6.
21. Miyamoto S; Japan Adult Moyamoya Trial Group: Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset - The Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 2004; 44: 218-219. (Pubitemid 38619411)
22. Kikuta K, Takagi Y, Nozaki K, Yamada K, Miyamoto S, Kataoka H, Arai T, Hashimoto N: Effects of intravenous anesthesia with propofol on regional cortical blood flow and intracranial pressure in surgery for moyamoya disease. Surg Neurol 2007; 68: 421-424. (Pubitemid 47464466)
23. Fujimura M, Kaneta T, Shimizu H, Tominaga T: Cerebral ischemia owing to compression of the brain by swollen temporal muscle used for encephalo-myo-synangiosis in moyamoya disease. Neurosurg Rev 2009; 32: 245-249.
24. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99(suppl 2):S238-S240. (Pubitemid 27489104)
25. Research on intractable disease of the Ministry of Health, Labour and Welfare, Japan. Recommendations for the Management of Moyamoya Disease. A Statement from Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) (in Japanese). Surg Cereb Stroke 2009; 37: 321-337.
26. Ikeda E, Hosoda Y: Distribution of thrombotic lesion in the cerebral arteries in spontaneous occlusion of the circle of Willis: Cerebrovascular moyamoya disease. Clin Neuropathol 1993; 12: 44-48. (Pubitemid 23041470)
27. Heros RC, Scott RM, Ackerman RH, Conner ES: Temporary neurological deterioration after extracranial-intracranial bypass. Neurosurgery 1984; 15: 178-185. (Pubitemid 14068909)
28. Kuroda S, Kamiyama H, Abe H, Asaoka K, Mitsumori K: Temporary neurological deterioration caused by hyperperfusion after extracranial- intracranial bypass: Case report and study of cerebral hemodynamics. Neurol Med Chir (Tokyo) 1994; 34: 15-19. (Pubitemid 24060450)
29. Yamaguchi K, Kawamata T, Kawashima A, Hori T, Okada Y: Incidence and predictive factors of cerebral hyperperfusion after extracranial-intracranial bypass for occlusive cerebrovascular diseases. Neurosurgery 2010; 67: 1548-1554.
30. Ogasawara K, Inoue T, Kobayashi M, Endo H, Fukuda T, Ogawa A: Pretreatment with the free radical scavenger edaravone prevents cerebral hyperperfusion after carotid endarterectomy. Neurosurgery 2004; 55: 1060-1067.
31. Huang AP, Liu HM, Yang CC, Tsai YH, Wang KC, Yang SH, Kuo MF, Tu YK: Clinical significance of posterior circulation changes after revascularization in patients with moyamoya disease. Cerebrovasc Dis 2009; 28: 247-257.
32. Komoribayashi N, Ogasawara K, Kobayashi M, Saitoh H, Terasaki K, Inoue T, Ogawa A: Cerebral hyperperfusion after carotid endarterectomy is associated with preoperative hemodynamic impairment and intraoperative cerebral ischemia. J Cereb Blood Flow Metab 2005; 26: 878-884.
33. Oka K, Yamashita M, Sadoshima S, Tanaka K: Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol 1981; 392: 247-261. (Pubitemid 11039285)
34. Takagi Y, Kikuta K, Nozaki K, Hashimoto N: Histological features of middle cerebral arteries from patients treated for Moyamoya disease. Neurol Med Chir (Tokyo) 2007; 47: 1-4. (Pubitemid 46168933)
35. Chan PH: Role of oxidants in ischemic brain injury. Stroke1996; 27: 1124-1129. (Pubitemid 26177617)
36. Kang HS, Kim JH, Phi JH, Kim YY, Wang KC, Cho BK, Kim SK: Plasma matrix metalloproteinases, cytokines and angiogenic factors in moyamoya disease. J Neurol Neurosurg Psychiatry 2010; 81: 673-678.
37. Sakamoto S, Kiura Y, Yamasaki F, Shibukawa M, Ohba S, Shrestha P, Sugiyama K, Kurisu K: Expression of vascular endothelial growth factor in dura matter of patients with moyamoya disease. Neurosurg Rev 2008; 31: 77-81. (Pubitemid 350165334)
38. Fujimura M, Watanabe M, Narisawa A, Shimizu H, Tominaga T: Increased expression of serum matrix metalloproteinase-9 in patients with moyamoya disease. Surg Neurol 2009; 72: 476-480.
39. Mikami C, Suzuki M, Tsuiki K, Ogawa A: Effect of nicardipine and magnesium on cerebral infarction-brain surface perfusion technique. Cerebrovasc Dis 2001; 11: 44-50. (Pubitemid 32098427)
40. Amenta F, Tomassoni D: Treatment with nicardipine protects brain in an animal model of hypertension-induced damage. Clin Exp Hypertens 2004; 26: 351-361. (Pubitemid 38691116)
41. Kawamata T, Kawashima A, Yamaguchi K, Hori T, Okada Y: Usefulness of intraoperative laser Doppler flowmetry and thermography to predict a risk of postoperative hyperperfusion after STA-MCA bypass for moyamoya disease. Neurosurg Rev 2011; 34: 355-362.